/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

L

Lauren E. Abrey

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

341

Papers

26.1K

Citations

82

h-index

185

i10-index

Lauren E. Abrey is an academic researcher. The author has contributed to research in topics: Glioma Diagnosis and Treatment & Brain Metastases and Treatment & CNS Lymphoma Diagnosis and Treatment. The author has an h-index of 82, co-authored 290 publications.

ORCID: 0009-0002-2035-2540

Research Topics

Glioma Diagnosis and Treatment Brain Metastases and Treatment CNS Lymphoma Diagnosis and Treatment Lymphoma Diagnosis and Treatment Radiomics and Machine Learning in Medical Imaging

Papers by this author

works

Patients With Proneural Glioblastoma May Derive Overall Survival Benefit From the Addition of Bevacizumab to First-Line Radiotherapy and Temozolomide: Retrospective Analysis of the AVAglio Trial

2015 · Journal of Clinical Oncology · 291 citations

https://doi.org/10.1200/jco.2015.61.5005

Thomas Sandmann Richard Bourgon Josep Garcia Congfen Li

Progression-free survival as a surrogate endpoint for overall survival in glioblastoma: a literature-based meta-analysis from 91 trials

2013 · Neuro-Oncology · 138 citations

https://doi.org/10.1093/neuonc/not236

Kelong Han Min Ren Wolfgang Wick Lauren E. Abrey

Antiangiogenic agents in the treatment of recurrent or newly diagnosed glioblastoma: Analysis of single-agent and combined modality approaches

2011 · Radiation Oncology · 91 citations

https://doi.org/10.1186/1748-717x-6-2

Kathryn Beal Lauren E. Abrey Philip H. Gutin

Supplemental Figure S1 from Depth of radiographic response (DpR) and time to tumor regrowth (TTG) predicts overall survival following anti-VEGF therapy in recurrent glioblastoma

2024 · 0 citations

https://doi.org/10.1158/1078-0432.27034138

Benjamin M. Ellingson Akifumi Hagiwara Connor J. Morris Nicholas S. Cho

Supplemental Figure S2 from Depth of radiographic response (DpR) and time to tumor regrowth (TTG) predicts overall survival following anti-VEGF therapy in recurrent glioblastoma

2024 · 0 citations

https://doi.org/10.1158/1078-0432.27034135

Benjamin M. Ellingson Akifumi Hagiwara Connor J. Morris Nicholas S. Cho

Supplemental Figure S2 from Depth of radiographic response (DpR) and time to tumor regrowth (TTG) predicts overall survival following anti-VEGF therapy in recurrent glioblastoma

2024 · 0 citations

https://doi.org/10.1158/1078-0432.27034135.v1

Benjamin M. Ellingson Akifumi Hagiwara Connor J. Morris Nicholas S. Cho

Research topics

topics

Glioma Diagnosis and Treatment

Brain Metastases and Treatment

CNS Lymphoma Diagnosis and Treatment

Lymphoma Diagnosis and Treatment

Radiomics and Machine Learning in Medical Imaging

Chat about Author

Papers

Chat

Click to start Chat